| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +17% |
| 3Y CAGR | -6% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +26% |
| 3Y CAGR | +7.0% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,856.00 +5.70 (0.15%) | 17,611.50 | 20.49 | 4.02 | ||
Natco PharmaNATCOPHARM | ₹814.30 -7.65 (0.93%) | 16,115.20 | 19.43 | 1.46 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,029.10 -55.50 (2.66%) | 15,851.48 | 22.64 | 4.06 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,167.50 +54.50 (0.89%) | 15,301.13 | 86.09 | 17.41 |